Education
About Us
Working with TipRanks
Follow Us
Biosergen AB (SE:BIOSGN)
:BIOSGN
BIOSGN Stock Chart & Stats
kr47.00
<kr0.01(1.20%)
At close: 4:00 PM EST
kr47.00
<kr0.01(1.20%)
Day’s Range― - ―
52-Week Rangekr28.10 - kr67.80
Previous CloseN/A
Volume13.64K
Average Volume (3M)126.26K
Market Cap
€109.66M
Enterprise Valuekr98.93M
Total Cash (Recent Filing)€33.27M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.53
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.18
Shares Outstanding234,823,210
10 Day Avg. Volume207,862
30 Day Avg. Volume126,261
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)2.64
Price to Sales (P/S)0.00
P/FCF Ratio-7.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biosergen AB News
BIOSGN FAQ
What was Biosergen AB’s price range in the past 12 months?
Biosergen AB lowest stock price was kr28.10 and its highest was kr67.80 in the past 12 months.
What is Biosergen AB’s market cap?
Biosergen AB’s market cap is €109.66M.
When is Biosergen AB’s upcoming earnings report date?
Biosergen AB’s upcoming earnings report date is Mar 27, 2026 which is in 104 days.
How were Biosergen AB’s earnings last quarter?
Biosergen AB released its earnings results on Nov 19, 2025. The company reported -kr5.182 earnings per share for the quarter, missing the consensus estimate of N/A by -kr5.182.
Is Biosergen AB overvalued?
According to Wall Street analysts Biosergen AB’s price is currently Overvalued.
Does Biosergen AB pay dividends?
Biosergen AB does not currently pay dividends.
What is Biosergen AB’s EPS estimate?
Biosergen AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosergen AB have?
Biosergen AB has 234,823,210 shares outstanding.
What happened to Biosergen AB’s price movement after its last earnings report?
Biosergen AB reported an EPS of -kr5.182 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of Biosergen AB?
Currently, no hedge funds are holding shares in SE:BIOSGN
Company Description
Biosergen AB
Biosergen AB (BIOSGN) is a biotechnology company focused on the research and development of novel antifungal therapies. The company operates in the healthcare sector, particularly within the pharmaceutical and biotechnology industries. Its core product pipeline includes innovative antifungal compounds aimed at addressing unmet needs in the treatment of fungal infections.
Technical Analysis
Alzinova AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―